购物车
- 全部删除
- 您的购物车当前为空
Tyrosinase-IN-35(compound 6g)作为一种优于Kojic Acid(IC50: 16.38 μM)的人类酪氨酸酶抑制剂(IC50: 2.09 μM),在4 μM及8 μM剂量下已证实可以有效减少黑色素瘤细胞B16F10体外的黑色素含量。
Tyrosinase-IN-35(compound 6g)作为一种优于Kojic Acid(IC50: 16.38 μM)的人类酪氨酸酶抑制剂(IC50: 2.09 μM),在4 μM及8 μM剂量下已证实可以有效减少黑色素瘤细胞B16F10体外的黑色素含量。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | Tyrosinase-IN-35 (compound 6g), exhibiting a IC 50 value of 2.09 μM, serves as a more effective inhibitor of human tyrosinase compared to Kojic Acid (IC 50: 16.38 μM). At concentrations of 4 μM and 8 μM, this compound effectively lowers melanin levels in melanoma B16F10 cells in vitro. |
分子量 | 337.4 |
分子式 | C17H15N5OS |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.